A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...

First-in-class immune-stimulating antibody conjugate BDC-4182 in Phase 1 dose escalation study, initial clinical data expected in 3Q 2026 Cash ...

Taking aim at the leading risk factor for cancer, The Mark Foundation for Cancer Research and the Samuel Waxman Cancer Research Foundation (SWCRF) today announced $2.5 million to support science at ...

KOMODO-1 first-in-human clinical trial of BBI-940 open for enrollment $108 million in cash provides runway into the second half of 2028, through expected clinical proof-of-concept readout for KOMODO-1 ...

REMSCHEID, Germany — March 3, 2026 — In the German research project bioPEtex, BB Engineering (BBE) is working with other partners to develop textiles made from 100% bio-based polyethylene (PE). The ...

To improve the treatment of patients with metastatic cancer, responsible for 67%-90% of all cancer-related deaths, there is an “urgent” need to abandon the classification of tumors by organ of origin, ...

Iovance Biotherapeutics' most important product has strong momentum right now. However, the company faces significant challenges that make the stock risky. Iovance could soar if it can overcome the ...

Aizawl: Preparatory work for the proposed Mizoram State Super Speciality Cancer and Research Centre (MSSSCRC) at Zemabawk is currently underway under a project funded by the Japan International ...

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients ...

Twelve projects in 12 counties have been approved for $13.5 million in state funding to support site and building development, Gov. Andy Beshear announced Thursday. The funding will support ...

In a boon for licensee Bristol Myers Squibb Co., Systimmune Inc.’s next-generation cancer drug, izalontamab brengitecan (iza-bren), hit both progression-free survival and overall survival endpoints in ...